Applied Clinical Trials Digital Edition August/September 2014

Article

Applied Clinical Trials

Applied Clinical TrialsApplied Clinical Trials-08-01-2014
Volume 23
Issue 8

CRO/Sponsor: Clinical Supply Survey, Strategies Sites: Fair Market Value Debate Clinical Technology: Optimizing Supply Chain Data Trial Design: Multi-site Pre-implementation Also in this issue: European Innovation Initiative, Part II Medicine Kits: The Patient Perspective Global Trials Need Strategic Touch

External Link - 2014-08ACT.pdf

Download Issue PDF
Articles in this issue
i4-852761-1416901227020.jpg
Clinical Supply Capabilities, Practices, and Perceptions Among Investigative Sites
i2-852770-1416901209323.gif
Efficient Pre-implementation of Multi-site Clinical Trials
i1-852759-1416901232290.jpg
A Shot in the Arm for European Clinical Trials?
pr-852763-1416901219720.jpg
Optimizing Trial Supplies Via Integrated e-Platforms
Clamor Grows to Expand Trial Participation of Women & Minorities
i1-852752-1416901247256.jpg
Breathe Easier: Cancer R&D Innovation Puts Strong Focus on the Lung
i1-852771-1416901207035.jpg
Strategic Approach Needed for International Clinical Trials
i1-852760-1416901229946.jpg
Study Volunteer Insights into Clinical Trial Medicine Kits
i3-852762-1416901222039.gif
Fair Market Conundrum: Solutions for Sponsors & Sites
EFGCP Warns About Risks of Overprotecting Data
Applied Clinical Trials Digital Edition August/September 2014
Recent Videos
Related Content
Preparing to Achieve with Joint Clinical Assessments

Preparing to Achieve with Joint Clinical Assessments

Graham Bell
June 11th 2025
Article

Strategies for sponsors in navigating the European Union's new health technology assessment regulation.

Unifying Industry to Better Understand GCP Guidance

Unifying Industry to Better Understand GCP Guidance

Andy Studna, Senior Editor
May 7th 2025
Podcast

In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.

What We Think We Know: How Overconfidence Derails Clinical Trials

What We Think We Know: How Overconfidence Derails Clinical Trials

Brian S. McGowan, PhD, FACEHP
June 11th 2025
Article

Overcoming the illusion of knowledge in clinical research can enhance decision-making, training, and project success—helping ensure trials run smoothly and effectively.

Site Logo

Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast

May 2nd 2025
Podcast
© LASZLO - © LASZLO - stock.adobe.com.

First Patient Dosed in Phase III Trial of Enhertu as First-Line Treatment for Endometrial Cancer

Andy Studna, Senior Editor
June 10th 2025
Article

In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 study for the treatment of patients with HER2-expressing, mismatch repair proficient primary advanced or recurrent endometrial cancer.

Credit: Dr_Microbe | stock.adobe.com. Lung cancer, medical concept, 3D illustration showing cancerous tumor inside human lung

Phase III DeLLphi-304 Trial Finds Imdelltra Significantly Extends Survival in Relapsed Small-Cell Lung Cancer

Davy James
June 10th 2025
Article

Phase III DeLLphi-304 results show T-cell engager Imdelltra (tarlatamab) delivers superior overall survival, improved progression-free survival, and better symptom control compared to chemotherapy in patients with small-cell lung cancer following platinum-based treatment.

© 2025 MJH Life Sciences

All rights reserved.